Encompass Health Corporation (EHC) Stock
EHC Key Statistics
About Encompass Health Corporation
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
CEO: Mark J. Tarr. Company website
EHC — Frequently Asked Questions
What is the EHC stock price today?
Encompass Health Corporation (EHC) trades at $121.75, down 1.13% on the day, as of Sep 20, 2026 14:59 UTC.
What is Encompass Health Corporation's market cap?
Encompass Health Corporation has a market capitalisation of $12.08B, calculated from the live EHC share price and shares outstanding.
What is the P/E ratio of EHC?
EHC trades at a trailing P/E of 19.83, from earnings per share of $6.14 over the last twelve months.
How much revenue does Encompass Health Corporation make?
Encompass Health Corporation generated revenue of $6.21B over the trailing twelve months, which puts the stock at 1.95 times sales.
Does EHC pay a dividend?
Yes. Encompass Health Corporation pays a dividend yielding 0.71% on the current share price.
What is the 52-week range for EHC?
EHC has traded between $92.77 and $127.86 over the past 52 weeks, and the last price is 4.8% below that high.
Is Encompass Health Corporation profitable?
Yes. Encompass Health Corporation keeps 10.01% of revenue as net income over the trailing twelve months.
What is the analyst price target for EHC?
Wall Street analysts rate EHC Buy, with an average price target of $150.25, 23.4% above the current price.
What sector is Encompass Health Corporation in?
Encompass Health Corporation is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in US.
Who is the CEO of Encompass Health Corporation?
Mark J. Tarr is the chief executive of Encompass Health Corporation, which employs 29,699 people.
Where can I track EHC in real time?
QFI Terminal shows EHC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See EHC live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open EHC in Terminal See plans